Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;19(3):169-74.
doi: 10.3747/co.19.931.

Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers

T Di Valentin  1 , Y Alam, A Ali Alsharm, S Arif, F Aubin, J Biagi, C M Booth, S Bourque, R Burkes, P Champion, B Colwell, C Cripps, M Dallaire, M Dorreen, N Finn, D Frechette, S Gallinger, J Gapski, C Giacomantonio, S Gill, R Goel, R Goodwin, L Grimard, A Grothey, N Hammad, D Hedley, K Jhaveri, D Jonker, Y Ko, M L'espérance, J Maroun, H Ostic, N Perrin, M Rother, E St-Hilaire, M Tehfe, M Thirlwell, S Welch, N Yarom, T Asmis
Affiliations

Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers

T Di Valentin et al. Curr Oncol. 2012 Jun.

Abstract

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Ottawa, Ontario, October 22-23, 2010. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer, such as the use of epidermal growth factor inhibitors in metastatic colon cancer, the benefit of calcium and magnesium with oxaliplatin chemotherapy, the role of microsatellites in treatment decisions for stage II colon cancer, the staging and treatment of rectal cancer, and the management of colorectal and metastatic pancreatic cancers.

Keywords: Consensus guideline; colorectal cancer; egfri; microsatellites; pancreatic cancer; rectal cancer.

PubMed Disclaimer

References

    1. Vickers M, Samson B, Colwell B, et al. Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol. 2010;17:70–7. - PMC - PubMed
    1. Canadian Task Force Methodology New grades for recommendations from the Canadian Task Force on Preventive Health Care [Table 1] CMAJ. 2003;169:207–8. [Available online at: http://www.canadiantaskforce.ca/recommendations/2003_04_eng.html; cited April 30, 2012] - PMC - PubMed
    1. Allegra CJ, Jessup JM, Somerfield MR, et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol. 2009;27:2091–6. doi: 10.1200/JCO.2009.21.9170. - DOI - PubMed
    1. Lacouture ME, Mitchell EP, Piperdi B, et al. Skin toxicity evaluation protocol with panitumumab (stepp), a phase ii, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol. 2010;28:1351–7. doi: 10.1200/JCO.2008.21.7828. - DOI - PubMed
    1. Van Cutsem E, Köhne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408–17. doi: 10.1056/NEJMoa0805019. - DOI - PubMed

LinkOut - more resources